{"id":"https://openalex.org/W3214744625","doi":"https://doi.org/10.1111/bju.15665","title":"Should patients with non\u2010muscle\u2010invasive bladder cancer discontinue fibrin clot inhibitors during bacille Calmette\u2013Gu\u00e9rin?","display_name":"Should patients with non\u2010muscle\u2010invasive bladder cancer discontinue fibrin clot inhibitors during bacille Calmette\u2013Gu\u00e9rin?","publication_year":2021,"publication_date":"2021-12-02","ids":{"openalex":"https://openalex.org/W3214744625","doi":"https://doi.org/10.1111/bju.15665","mag":"3214744625","pmid":"https://pubmed.ncbi.nlm.nih.gov/34854189","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11902302"},"language":"en","primary_location":{"id":"doi:10.1111/bju.15665","doi":"https://doi.org/10.1111/bju.15665","is_oa":false,"landing_page_url":"https://doi.org/10.1111/bju.15665","pdf_url":null,"source":{"id":"https://openalex.org/S191188855","display_name":"British Journal of Urology","issn_l":"1464-4096","issn":["1464-4096","1464-410X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BJU International","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11902302","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058914820","display_name":"Niyati Lobo","orcid":"https://orcid.org/0000-0002-6505-8399","observed_orcids":["https://orcid.org/0000-0002-6505-8399"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Niyati Lobo","raw_affiliation_strings":["Department of Urology University of Texas MD Anderson Cancer Center  Houston TX USA"],"raw_orcid":"https://orcid.org/0000-0002-6505-8399","affiliations":[{"raw_affiliation_string":"Department of Urology University of Texas MD Anderson Cancer Center  Houston TX USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036722177","display_name":"Patrick Joseph Hensley","orcid":"https://orcid.org/0000-0002-8098-901X","observed_orcids":["https://orcid.org/0000-0002-8098-901X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick J. Hensley","raw_affiliation_strings":["Department of Urology University of Texas MD Anderson Cancer Center  Houston TX USA"],"raw_orcid":"https://orcid.org/0000-0002-8098-901X","affiliations":[{"raw_affiliation_string":"Department of Urology University of Texas MD Anderson Cancer Center  Houston TX USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072980507","display_name":"Kelly K. Bree","orcid":"https://orcid.org/0000-0003-4532-7763","observed_orcids":["https://orcid.org/0000-0003-4532-7763"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kelly K. Bree","raw_affiliation_strings":["Department of Urology University of Texas MD Anderson Cancer Center  Houston TX USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology University of Texas MD Anderson Cancer Center  Houston TX USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018403822","display_name":"Graciela M. Nogueras\u2010Gonz\u00e1lez","orcid":"https://orcid.org/0000-0002-6350-2206","observed_orcids":["https://orcid.org/0000-0002-6350-2206"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Graciela M. Nogueras\u2010Gonzalez","raw_affiliation_strings":["Department of Biostatistics University of Texas MD Anderson Cancer Center  Houston TX USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics University of Texas MD Anderson Cancer Center  Houston TX USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002421938","display_name":"Neema Navai","orcid":"https://orcid.org/0000-0001-8457-3786","observed_orcids":["https://orcid.org/0000-0001-8457-3786"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neema Navai","raw_affiliation_strings":["Department of Urology University of Texas MD Anderson Cancer Center  Houston TX USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology University of Texas MD Anderson Cancer Center  Houston TX USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002737792","display_name":"Colin P. Dinney","orcid":"https://orcid.org/0000-0002-8969-711X","observed_orcids":["https://orcid.org/0000-0002-8969-711X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Colin P. Dinney","raw_affiliation_strings":["Department of Urology University of Texas MD Anderson Cancer Center  Houston TX USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology University of Texas MD Anderson Cancer Center  Houston TX USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034005227","display_name":"Ashish M. Kamat","orcid":"https://orcid.org/0000-0003-3546-9928","observed_orcids":["https://orcid.org/0000-0003-3546-9928"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ashish M. Kamat","raw_affiliation_strings":["Department of Urology University of Texas MD Anderson Cancer Center  Houston TX USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology University of Texas MD Anderson Cancer Center  Houston TX USA","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5034005227"],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":{"value":3950,"currency":"USD","value_usd":3950},"apc_paid":null,"fwci":0.4693,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.64005476,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"130","issue":"4","first_page":"463","last_page":"469"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-muscle-invasive-bladder-cancer","display_name":"non-muscle-invasive bladder cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/bcg-vaccine","display_name":"BCG vaccine","score":0.890999972820282},{"id":"https://openalex.org/keywords/intravesical-immunotherapy","display_name":"intravesical immunotherapy","score":0.8970000147819519},{"id":"https://openalex.org/keywords/aspirin","display_name":"aspirin","score":0.9480000138282776},{"id":"https://openalex.org/keywords/clopidogrel","display_name":"clopidogrel","score":1.0},{"id":"https://openalex.org/keywords/warfarin","display_name":"warfarin","score":0.9909999966621399},{"id":"https://openalex.org/keywords/direct-oral-anticoagulants","display_name":"direct oral anticoagulants","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tumor-recurrence","display_name":"tumor recurrence","score":0.9290000200271606},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9210000038146973},{"id":"https://openalex.org/keywords/anticoagulation-safety","display_name":"anticoagulant safety","score":0.5619999766349792}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9805896282196045},{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.7118352651596069},{"id":"https://openalex.org/C2777628954","wikidata":"https://www.wikidata.org/wiki/Q18216","display_name":"Aspirin","level":2,"score":0.694861650466919},{"id":"https://openalex.org/C2777849778","wikidata":"https://www.wikidata.org/wiki/Q410237","display_name":"Clopidogrel","level":3,"score":0.6176900863647461},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.5867674946784973},{"id":"https://openalex.org/C54173615","wikidata":"https://www.wikidata.org/wiki/Q27205","display_name":"Fibrin","level":2,"score":0.5846635103225708},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5690022110939026},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5471004247665405},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.5152040123939514},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.4813535809516907},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4527386426925659},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.41303756833076477},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.40203672647476196},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3327106833457947},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.13928383588790894},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.0},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077144","descriptor_name":"Clopidogrel","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000276","descriptor_name":"Adjuvants, Immunologic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000283","descriptor_name":"Administration, Intravesical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001241","descriptor_name":"Aspirin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001241","descriptor_name":"Aspirin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001500","descriptor_name":"BCG Vaccine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001749","descriptor_name":"Urinary Bladder Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D005337","descriptor_name":"Fibrin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013927","descriptor_name":"Thrombosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/bju.15665","doi":"https://doi.org/10.1111/bju.15665","is_oa":false,"landing_page_url":"https://doi.org/10.1111/bju.15665","pdf_url":null,"source":{"id":"https://openalex.org/S191188855","display_name":"British Journal of Urology","issn_l":"1464-4096","issn":["1464-4096","1464-410X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BJU International","raw_type":"journal-article"},{"id":"pmid:34854189","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34854189","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BJU international","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11902302","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11902302","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"BJU Int","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:11902302","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11902302","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"BJU Int","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[{"id":"https://openalex.org/G9000878657","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA016672","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320320177","display_name":"US-UK Fulbright Commission","ror":"https://ror.org/037nbwt68"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W1981901006","https://openalex.org/W1986277645","https://openalex.org/W1992984639","https://openalex.org/W1994396826","https://openalex.org/W2039218197","https://openalex.org/W2046411485","https://openalex.org/W2048775109","https://openalex.org/W2110317022","https://openalex.org/W2116195839","https://openalex.org/W2134589781","https://openalex.org/W2136763917","https://openalex.org/W2142721444","https://openalex.org/W2147633207","https://openalex.org/W2152206210","https://openalex.org/W2152445257","https://openalex.org/W2158993862","https://openalex.org/W2270022169","https://openalex.org/W2412154932","https://openalex.org/W2468333136","https://openalex.org/W3014619824","https://openalex.org/W3173331495"],"related_works":["https://openalex.org/W2046411485","https://openalex.org/W4241874038","https://openalex.org/W2468333136","https://openalex.org/W2136763917","https://openalex.org/W2412154932","https://openalex.org/W3173331495","https://openalex.org/W2403966563","https://openalex.org/W4220825417","https://openalex.org/W1981901006","https://openalex.org/W2708382523"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"determine":[2],"the":[3,61,143],"impact":[4,144],"of":[5,19,42,63,77,97,118,145,174,188],"fibrin":[6],"clot":[7],"inhibitor":[8],"(FCI)":[9],"use":[10,59,76,117,150,162,173],"on":[11,151,197],"oncological":[12,181],"outcomes":[13,182],"in":[14,183],"a":[15,102,184],"large":[16,185],"contemporary":[17,186],"cohort":[18,187],"patients":[20,43,99,189],"with":[21,27,44,47,166,179],"non-muscle-invasive":[22],"bladder":[23],"cancer":[24],"(NMIBC)":[25],"treated":[26,46],"adequate":[28,48,191],"bacille":[29],"Calmette-Gu\u00e9rin":[30],"(BCG).":[31],"PATIENTS":[32],"AND":[33],"METHODS:":[34],"We":[35],"performed":[36],"an":[37],"Institutional":[38],"Review":[39],"Board-approved":[40],"review":[41],"NMIBC":[45],"intravesical":[49,192],"BCG,":[50],"at":[51,60],"our":[52],"institution":[53],"between":[54],"2000":[55],"and":[56,81,89,110,132,153],"2018.":[57],"FCI":[58,78,161],"time":[62],"BCG":[64,193,206],"therapy":[65],"was":[66,155,163,176],"recorded":[67],"for":[68,194],"each":[69],"patient.":[70],"Patients":[71],"were":[72,84],"stratified":[73],"according":[74],"to":[75],"medication.":[79],"Recurrence-":[80],"progression-free":[82,127],"survival":[83,128],"analysed":[85],"using":[86],"Kaplan-Meier":[87],"methods":[88],"Cox":[90],"proportional":[91],"hazard":[92],"models.":[93],"RESULTS:":[94],"Overall,":[95],"226":[96],"526":[98],"(43.0%)":[100],"used":[101],"FCI:":[103],"aspirin":[104],"(205),":[105],"clopidogrel":[106,147],"(38),":[107],"warfarin":[108],"(18)":[109],"novel":[111],"oral":[112],"anticoagulant":[113],"(NOAC;":[114],"seven).":[115],"The":[116,172],"FCIs":[119,175,200],"did":[120,139],"not":[121,140,177],"adversely":[122],"affect":[123],"either":[124],"recurrence-":[125],"or":[126,148],"(P":[129],"=":[130,134],"0.385":[131],"P":[133],"0.131,":[135],"respectively).":[136],"These":[137],"results":[138],"change":[141],"when":[142],"aspirin,":[146],"warfarin/NOAC":[149],"recurrence":[152,168],"progression":[154],"evaluated":[156],"separately.":[157],"On":[158],"multivariate":[159],"analysis,":[160],"neither":[164],"associated":[165,178],"tumour":[167],"nor":[169],"progression.":[170],"CONCLUSION:":[171],"adverse":[180],"receiving":[190],"NMIBC.":[195],"Based":[196],"these":[198],"results,":[199],"may":[201],"be":[202],"safely":[203],"continued":[204],"during":[205],"immunotherapy.":[207]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2021-12-06T00:00:00"}